Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa Dosing Frequency in CKD Anemia
NCT00925587Phase 3Completed
- Sponsor
- Amgen
- Start
- Jun 2009
- Primary completion
- Apr 2012
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 23
01
Overview
A Phase 3 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started Jun 2009; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00925587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00925587.